-- (BUSINESS WIRE) -- DiscoveryBioMed, Inc. is a life sciences and biotechnology company focused on integrating physiologically and disease relevant human cell platforms into the Drug Discovery Critical Path. In addition to our own discovery R&D, we offer services work in custom primary and immortal human cell culture and engineering and human cell-based bioassay and platform design for drug discovery and development. DBM offers its custom human cell-based methods as a “fee-for-service” support to researchers in both the commercial and academic spaces at the level of drug discovery, drug validation and/or lead prioritization in a number of different therapeutic areas. For more information, visit the DBM website at www.discoverybiomed.com.
|
Company: |
DiscoveryBioMed, Inc. | |
|
Headquarters Address: |
400 Riverhills Business Park, Suite 435 | |
| Birmingham, AL 35242-8101 | ||
|
Main Telephone: |
205-918-8138 ext 2 |
|
|
Website: |
||
|
Type of Organization: |
Private | |
|
Industry: |
Biotechnology | |
|
Key Executives: |
CEO: Erik Schwiebert |
|
|
Head of Business Development: Joe Ritchie |
||
|
Head of Business Development |
||
|
Contact: |
Joe Ritchie | |
|
Phone: |
205-918-8138 ext 2 | |
|
Email: |
||
|
CEO |
||
|
Contact: |
Erik Schwiebert | |
|
Phone: |
205-918-8138 ext 1 | |
|
Email: |